In the presence of IL-2, Vδ1 T cells predominate in patients with glioblastoma, with enhanced immunosuppressive function of Vδ1 T cells and reduced cytotoxicity of Vδ2 T cells. The gene discussed is IL2; the disease is glioblastoma.